Glioblastoma Cells Counteract PARP Inhibition through Pro-Survival Induction of Lipid Droplets Synthesis and Utilization
Glioblastoma multiforme (GBM) is the most common and aggressive primary brain tumor in adults. Poly (ADP-ribose) polymerase inhibitors (PARPi) represent a new class of anti-neoplastic drugs. In the current study, we have characterized the mechanism by which glioblastoma cells evade the effect of PAR...
Main Authors: | Jara Majuelos-Melguizo, José Manuel Rodríguez-Vargas, Nuria Martínez-López, Daniel Delgado-Bellido, Ángel García-Díaz, Víctor J. Yuste, Marina García-Macía, Laura M. López, Rajat Singh, F. J. Oliver |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/3/726 |
Similar Items
-
BRCAness as a Biomarker of Susceptibility to PARP Inhibitors in Glioblastoma Multiforme
by: Mary-Ann Xavier, et al.
Published: (2021-08-01) -
Beyond energy provider: multifunction of lipid droplets in embryonic development
by: Tai Li, et al.
Published: (2023-07-01) -
Lipid Droplets in Health and Disease
by: Gizem Onal, et al.
Published: (2017-06-01) -
Molecular Machinery of Lipid Droplet Degradation and Turnover in Plants
by: Zhaoxia Qin, et al.
Published: (2023-11-01) -
Neuroprotective and Anti-Inflammatory Effects of Linoleic Acid in Models of Parkinson’s Disease: The Implication of Lipid Droplets and Lipophagy
by: Jesus Alarcon-Gil, et al.
Published: (2022-07-01)